OptraScan

OptraSCAN is a private, revenue-generating digital health company focused on the diagnostics sector. It offers a vertically integrated platform combining hardware (whole slide scanners), software (image management and telepathology), and AI-based analytics to digitize and enhance pathology workflows. The company targets clinical pathologists, researchers, and universities with flexible, scalable solutions, including novel pay-per-use AI models and specific applications for tuberculosis monitoring and breast cancer diagnostics. Its growth is driven by the global shift towards digital pathology and AI-augmented diagnostics.

Integrated digital pathology platform comprising proprietary whole slide scanners (brightfield & fluorescence), HIPAA-compliant image management software (IMAGEPath), telepathology tools, and AI-based analytics for automated tissue analysis.

Competes with large integrated players like Roche (Ventana), Philips, and Leica Biosystems, as well as pure-play AI software companies like Paige and PathAI. Differentiation lies in offering a full-stack, scalable solution with flexible purchasing models for hardware and AI.